CNER — BioEnergy Development Share Price
Last trade - 00:00- $58.74m
- $86.77m
- $11.77m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 4.7 | ||
| EV to EBITDA | 17.85 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | 35.01% | ||
Financial Summary
| Year End 31st Dec | Unit | 2005 | 2006 | 2007 | 2008 | 2009 | 2010E | 2011E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | 5.49 | 11.77 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
BioEnergy Development Inc., doing business as Syngas BioEnergy Corporation, is an energy company that builds and operates micro-energy grids for farmers. The Company is focused on converting biowaste into energy, addressing both the environmental crisis due to cattle farming and energy shortages in high-demand locations. It focuses on finance and scale solutions that convert organic waste into renewable energy, carbon-negative byproducts, and sustainable agricultural inputs. It partners with entities to commercialize decentralized, on-site energy systems that meet the need for power. Its focus is on deploying modular bioreactor technology to convert manure, crop residue, and forestry waste into syngas, biochar, and nutrient-rich outputs. These containerized systems are prebuilt, portable, and scalable, designed for rapid installation directly at the waste source. Each reactor powers industrial agriculture with up to 36 MWh per day of clean thermal energy.
Directors
- Yangkan Chong CHM (57)
- Tak Shing Yu CFO
- Dunhong Shi COO (50)
- Mary Fellows DRC (44)
- Chunming Guo DRC (52)
- John Kuhns DRC (64)
- Tie Li DRC (63)
- Shadron Stastney DRC (46)
- Last Annual
- December 31st, 2009
- Last Interim
- September 30th, 2010
- Incorporated
- January 11th, 2024
- Public Since
- September 11th, 2003
- No. of Shareholders
- 97
- No. of Employees
- 130
- Sector
- Electric Utilities & IPPs
- Industry
- Utilities
- Exchange
- Pink Sheets on Nasdaq
- Shares in Issue
- 7,342,532,492
- Address
- 8514 S Sagewood Rd, SPOKANE, 99223
- Web
- Phone
- Auditors
- Child , Van Wagoner & Bradshaw , PLLC
Similar to CNER
3Power Energy
Pink Sheets on Nasdaq
Acadia Energy
Pink Sheets on Nasdaq
Alaska Power & Telephone Co
Pink Sheets on Nasdaq
Alpine Auto Brokers
Pink Sheets on Nasdaq
Alternative Energy Technology
Pink Sheets on Nasdaq
FAQ
As of Today at 19:55 UTC, shares in BioEnergy Development are trading at $0.01. This share price information is delayed by 15 minutes.
Shares in BioEnergy Development last closed at $0.01 and the price had moved by -41.82% over the past 365 days. In terms of relative price strength the BioEnergy Development share price has underperformed the S&P500 Index by -46.91% over the past year.
There is no consensus recommendation for this security.
Find out moreBioEnergy Development does not currently pay a dividend.
BioEnergy Development does not currently pay a dividend.
BioEnergy Development does not currently pay a dividend.
To buy shares in BioEnergy Development you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.01, shares in BioEnergy Development had a market capitalisation of $58.74m.
Here are the trading details for BioEnergy Development:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: CNER
Based on an overall assessment of its quality, value and momentum BioEnergy Development is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like BioEnergy Development. Over the past six months, its share price has outperformed the S&P500 Index by +51.72%.
As of the last closing price of $0.01, shares in BioEnergy Development were trading -57.33% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The BioEnergy Development PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.01.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
BioEnergy Development's management team is headed by:
- Yangkan Chong - CHM
- Tak Shing Yu - CFO
- Dunhong Shi - COO
- Mary Fellows - DRC
- Chunming Guo - DRC
- John Kuhns - DRC
- Tie Li - DRC
- Shadron Stastney - DRC